ADEM & NMO
- ADEM (acute disseminated encephalomyelitis) is a one-time, post-infection/post-vaccination immune storm in the brain — usually in kids, monophasic, with multiple big fluffy white-matter lesions that all look the same age.
- NMOSD (neuromyelitis optica spectrum disorder) is a relapsing, antibody-driven disease (usually anti-aquaporin-4) that loves two targets: the optic nerves and the spinal cord.
- The NMO cord lesion is longitudinally extensive — it stretches over three or more vertebral segments, which is its signature trick.
- Both are demyelinating mimics of multiple sclerosis, and telling them apart changes treatment, so the distinction matters.
- Clinical timeline plus lesion pattern, not any single picture, makes the diagnosis.
Demyelinating disease is basically your immune system stripping the insulation off your nervous system's wiring. Multiple sclerosis is the famous one, but it has two cousins that show up on imaging and love to be confused with it — and with each other. Knowing them is the difference between treating the right disease and treating a category error.
ADEM: the one-and-done immune tantrum
ADEM is what happens when your immune system fights off an infection (or, less often, reacts after a vaccine), gets a little too enthusiastic, and turns its weapons on your own myelin on the way out. Picture a security guard who chases an intruder out of the building and then, still amped up, starts tackling the furniture. It's a single overreaction, not an ongoing campaign.
That "single overreaction" part is the whole personality of ADEM. It's typically monophasic — one episode, usually in a child, often a couple of weeks after a viral illness — and it doesn't keep relapsing the way MS does. Clinically these kids are often encephalopathic: confused, drowsy, not themselves. That altered mental status is a big hint, because plain MS usually doesn't scramble consciousness like that.
What ADEM looks like
On MRI you get multiple large, fluffy, poorly marginated lesions scattered through the white matter, and frequently the deep gray matter too — the thalami and basal ganglia get involved in a way MS tends to avoid.
The single most useful feature is timing: because it was all one immune event, the lesions are all roughly the same age. They tend to enhance together or not at all, rather than showing the "some old, some new" mix you expect in MS.
In ADEM the lesions are all the same vintage — one immune insult, one crop of lesions. MS, by contrast, is defined by dissemination in time: lesions of different ages coexisting.
NMOSD: the antibody that hunts two targets
Neuromyelitis optica spectrum disorder is a different animal entirely. This one is relapsing — it comes back — and most cases are driven by a specific antibody against aquaporin-4 (AQP4), a water channel that happens to be densely packed on the astrocytes guarding the optic nerves and spinal cord. The antibody is basically a heat-seeking missile, and those two structures are the heat.
So the classic NMOSD patient gets optic neuritis (painful vision loss, sometimes both eyes) and transverse myelitis (a cord syndrome). The brain can be involved too, often in spots rich in aquaporin-4 like the area around the third and fourth ventricles, but the optic nerves and cord are the headliners.
The longitudinally extensive cord lesion
Here is NMOSD's signature, and it's worth tattooing on the inside of your eyelids: the spinal cord lesion is longitudinally extensive transverse myelitis (LETM) — a swollen, bright-on-T2 lesion that runs three or more vertebral segments up the cord and tends to sit centrally, soaking the gray matter.
That length is the tell. MS cord lesions are typically short — a segment or less — and peripheral. NMOSD draws a long stripe; MS dabs a short fleck.
Don't reflexively call every cord demyelination "MS." A long, central, swollen T2 lesion spanning three-plus vertebral bodies should make you think NMOSD and reach for the AQP4 antibody, because the treatments diverge — and some MS drugs can actually make NMOSD worse.
Sorting the three demyelinators
Because these blur together, a side-by-side is the fastest way to keep them straight.
| Feature | ADEM | NMOSD | Multiple Sclerosis |
|---|---|---|---|
| Course | Monophasic (usually) | Relapsing | Relapsing-remitting |
| Typical patient | Child, post-infection | Adult, often female | Young-to-middle adult |
| Encephalopathy | Common | Uncommon | Uncommon |
| Brain lesions | Large, fluffy, same age; deep gray matter | AQP4-rich zones (periventricular) | Ovoid, perivenular, different ages |
| Cord lesion | Can occur | Long (3+ segments), central | Short (<2 segments), peripheral |
| Key marker | Clinical timeline | Anti-AQP4 (or anti-MOG) | Oligoclonal bands, dissemination in time/space |
A quick caveat, because real medicine is fuzzy: a subset of patients — especially kids with ADEM-like or recurrent optic neuritis — carry anti-MOG antibodies instead, now grouped as MOG antibody-associated disease (MOGAD). The categories overlap at the edges, and the antibody panel often settles arguments the MRI can't.
The one thing to carry out
Don't anchor on a single slice. The diagnosis lives in the pattern over time: ADEM is one big simultaneous flare in a sick child, NMOSD is a relapsing antibody disease that targets the optic nerves and draws a long cord stripe, and MS is the lesions-of-many-ages disease. When the picture is ambiguous, pairing the MRI with the clinical course and the antibody panel — not squinting harder at the brain MRI — is what gets you to the right answer.